---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-083513"
form_type: "8-K"
ticker: "SXTP"
cik: "0001946563"
company_name: "60 DEGREES PHARMACEUTICALS, INC."
filed_at: "2023-11-03T23:59:59+00:00"
generated_at: "2026-06-08T22:47:29.713283+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# 60 Degrees Pharmaceuticals receives Nasdaq deficiency notice for bid price non-compliance

## Summary
- On Nov 2, 2023, Nasdaq notified SXTP that its common stock failed to maintain minimum $1.00 closing bid price for 30 consecutive business days through Nov 1, 2023.
- The company has a 180-day compliance period until April 30, 2024 to regain compliance with the Bid Price Rule.
- If not compliant by April 30, 2024, SXTP may be eligible for an additional 180-day period if it meets other listing standards.
- Failure to regain compliance may result in delisting of common stock and warrants from Nasdaq Capital Market.
- The company is evaluating options to regain compliance, including potential reverse stock split.

## SEC filing metadata
- accession: 0001213900-23-083513
- form_type: 8-K
- ticker: SXTP
- cik: 0001946563
- company_name: 60 DEGREES PHARMACEUTICALS, INC.
- filed_at: 2023-11-03T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1946563/000121390023083513/0001213900-23-083513-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1946563/000121390023083513/ea187691-8k_60degrees.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-083513
- JSON: https://secwatch.observer/filing/0001213900-23-083513.json
- Plain text: https://secwatch.observer/filing/0001213900-23-083513.txt

## Key facts
- Listing & Compliance Notices
  60 DEGREES PHARMACEUTICALS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: arket pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1946563/000121390023083513/0001213900-23-083513-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.